- 1. Patient's blood collected outside the body
- 2. Concentrating the patient's whole blood
- 3. Re-infusing the whole blood
4. The Hemobag® reduces risks
What Is It?
The Hemobag® is a product and a method that is used for concentrating anticoagulated whole blood using a technique that will allow for quick return of all blood components (Red Cells, Platelets, Plasma Proteins) back to the patient, in a concentrated form.
Unlike most forms of blood salvage that only save the red blood cells, the Hemobag® preserves all of the components necessary for coagulation. The Hemobag may be used for any procedure where large volumes of anticoagulated blood have been salvaged and or remain in an anticoagulated circuit; the primary focus is the volume of diluted blood that remains in a heart/lung machine circuit (cannula-to-cannula) after the cardiopulmonary bypass system has been disconnected from the patient at the end of surgery which is similar in every case.
Both patient and laboratory studies have consistently demonstrated improved blood parameter values using the Hemobag® versus other methods. No other product or method used in cardiac surgery, for blood processing, has demonstrated the improved blood component parameters for all blood components. The salvage, concentration and return of all blood components are essential for the stability, coagulation and homeostasis of the surgical patients exposed to hemodilution and blood loss.
No other product or method used in cardiac surgery, for blood processing, has demonstrated the improved blood component parameters for all blood components that the Hemobag® can.
In addition to the clinical benefit of helping to eliminate donor blood component exposure, the Hemobag® helps reduce the overall cost of the procedure. Through minimizing or eliminating blood component administration, which is very costly, and improving recovery times, the Hemobag® has demonstrated significant cost reductions.